Silicosis (55 cases) |
≤1.04 mg/m3 years | 4 | 40 | 1.00 | – | – | <0.001 |
1.05–3.64 mg/m3 years | 5 | 38 | 2.02 | 0.45 to 9.09 | 0.358 | |
3.65–6.71 mg/m3 years | 13 | 30 | 8.62 | 1.86 to 39.95 | 0.006 | |
6.72–10.21 mg/m3 years | 17 | 27 | 12.36 | 2.67 to 57.2 | 0.001 | |
>10.21 mg/m3 years | 16 | 27 | 10.55 | 2.30 to 48.4 | 0.002 | |
Other non-malignant respiratory disease (172 cases) |
≤0.36 mg/m3 years | 38 | 92 | 1.00 | – | – | 0.318 |
0.37–1.18 mg/m3 years | 28 | 97 | 0.67 | 0.37 to 1.19 | 0.170 | |
1.19–2.57 mg/m3 years | 31 | 94 | 0.76 | 0.43 to 1.33 | 0.331 | |
2.58–5.41 mg/m3 years | 28 | 99 | 0.68 | 0.37 to 1.25 | 0.271 | |
>5.41 mg/m3 years | 47 | 79 | 1.39 | 0.76 to 2.54 | 0.279 | |
Lung cancer (356 cases) |
≤0.26 mg/m3 years | 84 | 241 | 1.00 | — | — | 0.316 |
0.26–0.82 mg/m3 years | 56 | 176 | 0.87 | 0.56 to 1.29 | 0.481 | |
0.82–2.09 mg/m3 years | 91 | 206 | 1.28 | 0.90 to 1.83 | 0.170 | |
2.09–4.10 mg/m3 years | 74 | 167 | 1.29 | 0.87 to 1.89 | 0.202 | |
> 4.10 mg/m3 years | 51 | 151 | 0.96 | 0.60 to 1.54 | 0.880 | |
Kidney cancer (28 cases) |
≤0.49 mg/m3 years | 9 | 14 | 1.00 | – | – | 0.967 |
0.50–1.42 mg/m3 years | 3 | 19 | 0.22 | 0.05 to 1.07 | 0.061 | |
1.43–2.54 mg/m3 years | 2 | 20 | 0.49 | 0.16 to 1.52 | 0.217 | |
2.55–4.41 mg/m3 years | 7 | 16 | 1.68 | 0.37 to 7.69 | 0.505 | |
>4.41 mg/m3 years | 7 | 15 | 0.90 | 0.20 to 3.97 | 0.886 | |
Non-malignant kidney disease (32 cases) |
≤0.68 mg/m3 years | 7 | 18 | 1.00 | – | – | 0.919 |
0.69–1.66 mg/m3 years | 5 | 20 | 0.61 | 0.17 to 2.17 | 0.446 | |
1.67–3.19 mg/m3 years | 7 | 18 | 1.04 | 0.32 to 3.34 | 0.945 | |
3.20–6.01 mg/m3 years | 7 | 18 | 1.09 | 0.26 to 4.52 | 0.904 | |
>6.01 mg/m3 years | 6 | 19 | 0.76 | 0.19 to 3.06 | 0.704 | |